Histotripsy methods in mechanical disintegration of tissue: towards clinical applications
- PMID: 25707817
- PMCID: PMC4448968
- DOI: 10.3109/02656736.2015.1007538
Histotripsy methods in mechanical disintegration of tissue: towards clinical applications
Abstract
In high intensity focused ultrasound (HIFU) therapy, an ultrasound beam is focused within the body to locally affect the targeted site without damaging intervening tissues. The most common HIFU regime is thermal ablation. Recently there has been increasing interest in generating purely mechanical lesions in tissue (histotripsy). This paper provides an overview of several studies on the development of histotripsy methods toward clinical applications. Two histotripsy approaches and examples of their applications are presented. In one approach, sequences of high-amplitude, short (microsecond-long), focused ultrasound pulses periodically produce dense, energetic bubble clouds that mechanically disintegrate tissue. In an alternative approach, longer (millisecond-long) pulses with shock fronts generate boiling bubbles and the interaction of shock fronts with the resulting vapour cavity causes tissue disintegration. Recent preclinical studies on histotripsy are reviewed for treating benign prostatic hyperplasia (BPH), liver and kidney tumours, kidney stone fragmentation, enhancing anti-tumour immune response, and tissue decellularisation for regenerative medicine applications. Potential clinical advantages of the histotripsy methods are discussed. Histotripsy methods can be used to mechanically ablate a wide variety of tissues, whilst selectivity sparing structures such as large vessels. Both ultrasound and MR imaging can be used for targeting and monitoring the treatment in real time. Although the two approaches utilise different mechanisms for tissue disintegration, both have many of the same advantages and offer a promising alternative method of non-invasive surgery.
Keywords: High intensity focused ultrasound; physics; ultrasound.
Figures










References
-
- Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: Current potential and oncologic applications. AJR Am J Roentgenol. 2008;190(1):191–199. - PubMed
-
- Kim YS, Kim JH, Rhim H, Lim HK, Keserci B, Bae DS, et al. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes. Radiology. 2012;263(2):600–609. - PubMed
-
- Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, et al. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol. 2014;65(5):907–914. - PubMed
-
- Wu F, Wang ZB, Chen WZ, Wang W, Gui Y, Zhang M, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: An overview. Ultrason Sonochem. 2004;11:149–154. - PubMed
Publication types
MeSH terms
Grants and funding
- K01EB015745/EB/NIBIB NIH HHS/United States
- EB007643/EB/NIBIB NIH HHS/United States
- EB008998/EB/NIBIB NIH HHS/United States
- P01 DK043881/DK/NIDDK NIH HHS/United States
- R01 EB007643/EB/NIBIB NIH HHS/United States
- R01 CA134579/CA/NCI NIH HHS/United States
- R01 EB008998/EB/NIBIB NIH HHS/United States
- CA134579/CA/NCI NIH HHS/United States
- T32 DK007779/DK/NIDDK NIH HHS/United States
- K01 EB015745/EB/NIBIB NIH HHS/United States
- R01 DK091267/DK/NIDDK NIH HHS/United States
- T32DK007779/DK/NIDDK NIH HHS/United States
- P01DK043881/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources